» Articles » PMID: 6288502

Activities of Various Enzymes of Pyrimidine Nucleotide and DNA Syntheses in Normal and Neoplastic Human Tissues

Overview
Journal Gan
Specialty Oncology
Date 1982 Apr 1
PMID 6288502
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

The activities of the key enzymes of pyrimidine nucleotide and DNA syntheses in 43 human tumors and 28 normal human tissues were investigated. The activities of cytidine triphosphate synthetase, deoxycytidine monophosphate deaminase, uridine kinase, thymidine kinase, thymidine monophosphate kinase and DNA polymerase were markedly increased in tumor tissues, compared with those in the corresponding normal tissues, while the activities of deoxycytidine kinase, cytidine deaminase and deoxycytidine deaminase were only slightly increased. The use of thymidine and deoxyuridine as substrates of human pyrimidine nucleoside phosphorylase gave 1 to 2 orders of magnitude higher activity than that of uridine.

Citing Articles

Lineage of drug discovery research on fluorinated pyrimidines: chronicle of the achievements accomplished by Professor Setsuro Fujii.

Maehara Y, Oki E, Ota M, Harimoto N, Ando K, Nakanishi R Int J Clin Oncol. 2023; 28(5):613-624.

PMID: 36961615 DOI: 10.1007/s10147-023-02326-w.


Biodistribution, Tumor Detection, and Radiation Dosimetry of F-5-Fluoro-2'-Deoxycytidine with Tetrahydrouridine in Solid Tumors.

Young C, Adler S, Eary J, Lindenberg M, Jacobs P, Collins J J Nucl Med. 2018; 60(4):492-496.

PMID: 30389817 PMC: 6448462. DOI: 10.2967/jnumed.118.216994.


A novel antimetabolite: TAS-102 for metastatic colorectal cancer.

Miyamoto Y, Lenz H, Baba H Expert Rev Clin Pharmacol. 2015; 9(3):355-65.

PMID: 26677869 PMC: 7485169. DOI: 10.1586/17512433.2016.1133285.


A nucleoside anticancer drug, 1-(3-C-ethynyl-β-D-ribo-pentofuranosyl)cytosine (TAS106), sensitizes cells to radiation by suppressing BRCA2 expression.

Meike S, Yamamori T, Yasui H, Eitaki M, Matsuda A, Morimatsu M Mol Cancer. 2011; 10:92.

PMID: 21798026 PMC: 3161955. DOI: 10.1186/1476-4598-10-92.


Thymidylate synthase gene expression in primary tumors predicts activity of s-1-based chemotherapy for advanced gastric cancer.

Takiuchi H, Kawabe S, Gotoh M, Katsu K Gastrointest Cancer Res. 2009; 1(5):171-6.

PMID: 19262706 PMC: 2632528.